Dosage-dependent requirement for mouse Vezf1 in vascular system development - Wikidata - awgldk - TriplyDB

Dosage-dependent requirement for mouse Vezf1 in vascular system development

Dosage-dependent requirement for mouse Vezf1 in vascular system development

http://www.wikidata.org/entity/Q28506356

about

Development of the mammalian lymphatic vasculature Regulation of mammalian Notch signaling and embryonic development by the protein O-glucosyltransferase Rumi RhoB controls coordination of adult angiogenesis and lymphangiogenesis following injury by regulating VEZF1-mediated transcription.Complete biallelic insulation at the H19/Igf2 imprinting control region position results in fetal growth retardation and perinatal lethality Lymphatic vascular morphogenesis in development, physiology, and disease A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish.Chromatin domains, insulators, and the regulation of gene expression Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b Genome-wide profiling of in vivo LPS-responsive genes in splenic myeloid cells.Vascular potential of human pluripotent stem cells Why increased nuchal translucency is associated with congenital heart disease: a systematic review on genetic mechanisms.Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice.Neurotrophin p75 receptor (p75NTR) promotes endothelial cell apoptosis and inhibits angiogenesis: implications for diabetes-induced impaired neovascularization in ischemic limb muscles Targeted Vezf1-null mutation impairs vascular structure formation during embryonic stem cell differentiation.Inhibition of microRNA-495 Enhances Therapeutic Angiogenesis of Human Induced Pluripotent Stem Cells.Triazole-induced toxicity in developing rare minnow (Gobiocypris rarus) embryos.CREB5 computational regulation network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients.Human synovial sarcoma proto-oncogene Syt is essential for early embryonic development through the regulation of cell migration.

P2860

Q26852649-DA2F8320-9D0B-4D50-8EAA-87599EA095A5 Q28507731-2C81D589-8A3C-40B9-9AD8-6686CDEE07C5 Q30560112-F4A34DD9-D454-4D11-9E20-70685CBAA902 Q33691538-126934BF-B9D5-4546-9C73-9ADE8BA8ADEE Q35196040-C0FFAE4C-E884-4E79-9A76-E69B1F64C263 Q35956832-75359895-0AC6-424E-92CB-2FA86AECB704 Q36358596-539AABD5-C3A9-4283-A057-0F3583161344 Q36802984-6FBD4869-2754-4F67-85E4-BFA9570DBA9A Q37462198-32A604FE-C956-4A5A-BD1A-A31AC91C8553 Q37746580-1CE875B7-4F9B-4B5D-B9A3-300679384A53 Q38366535-78E7734D-1756-4FA7-AEFF-3D85CA5E8D5D Q39849585-3233736B-109A-4153-9F10-6D72AA6214D8 Q42148995-7731EE53-B988-43A7-8343-DF95AA4F5BF2 Q42733613-6BF95E9C-0430-45E2-9BD2-3E7A714503C0 Q49108639-5A0A1E09-8762-4B70-BBC2-B5E60AD139EE Q50648551-46B911C7-1490-446E-8333-D73D3121BF69 Q51610237-CBADC2E7-F6D9-4CAF-B75D-32B98150303D Q51743748-A3D47662-A110-4646-9320-F5237905378D

P2860

Dosage-dependent requirement for mouse Vezf1 in vascular system development

http://www.wikidata.org/entity/Q28506356

description

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2005

@ast

im Juli 2005 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2005/07/01)

@sk

vědecký článek publikovaný v roce 2005

@cs

wetenschappelijk artikel (gepubliceerd op 2005/07/01)

@nl

наукова стаття, опублікована в липні 2005

@uk

مقالة علمية (نشرت في يوليو 2005)

@ar

name

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@ast

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@en

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@nl

type

label

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@ast

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@en

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@nl

prefLabel

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@ast

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@en

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@nl

P1433

Q28506356-605D2938-EC8D-4D3E-BE8C-B076F172450D

P1476

Q28506356-B1FF758B-57DD-42B3-9534-E207C4A0031D

P2093

Q28506356-042D2DB7-3C41-4825-B51B-D9E678CDA7E5

Q28506356-72372497-E32C-4F3A-B6F0-B976E8B3617E

Q28506356-83C33E62-BD1F-4C8C-AC75-C37080670398

Q28506356-84C6AB52-BE96-46A5-8299-E1B174B3A422

Q28506356-A3729758-AB3B-417C-8C5F-3AA18E70D587

Q28506356-B24EE60F-E8F7-4F01-BE9C-37CFB6800817

Q28506356-E2535944-A0CC-4837-A7ED-5030AC396D92

P2860

Q28506356-004E6838-E8AB-4846-91FB-AE2E44A86007

Q28506356-047C7E0F-96D0-4697-B442-8E380C12A390

Q28506356-0CD0854A-B626-48B2-AFBA-97B46193008E

Q28506356-0E173FD3-D4FA-4C45-B870-96871742D8C6

Q28506356-13FDFF0D-513D-4D91-8404-4E5C06326B33

Q28506356-14644F01-E9E9-40D8-8241-9FD0716A6CB3

Q28506356-20BA9E60-4FD6-4FA0-B478-E3DBD13A2A10

Q28506356-290211AA-A86C-4469-823F-C23767A8DED5

Q28506356-2D7C5804-80F0-47B3-BBD6-321ABBD56205

Q28506356-435E3C7D-DB6A-4198-BEAA-82AF9679AAEE

P304

Q28506356-4A88E71C-46E3-43EB-BEFA-BCCF31BA2926

P31

Q28506356-B32CB976-1A3B-45FF-86E4-A9E32EA98120

P356

Q28506356-F55A02E5-7398-4712-90E2-3AA75555A946

P407

Q28506356-4BE39CE6-D03A-4529-83B5-210C17C3988F

P433

Q28506356-9BF956E6-C28A-490A-97A4-2FD274BF6210

P478

Q28506356-5AE344F5-72CD-4F88-981A-07CE597F0683

P50

Q28506356-16D19713-1E8B-4A59-BD33-3345A6EB32F7

Q28506356-25937F00-0AEC-42FC-8CA6-3BB895BC7A34

P577

Q28506356-02858C35-7C17-43C4-8D27-FF81B8FE9D1C

P5875

Q28506356-0A05EC0F-51D9-42AD-A93D-13B83090ACFD

P698

Q28506356-63B06B90-2FAB-43B7-929F-E7EC7CE0B50A

P932

Q28506356-8EF594A0-2DA3-4FA1-8042-B455F33FDB6C

P356

J.YDBIO.2005.04.003

P1433

Developmental Biology

P1476

Dosage-dependent requirement for mouse Vezf1 in vascular system development

@en

P2093

Derek Lemons

http://www.w3.org/2001/XMLSchema#string

Frank Kuhnert

http://www.w3.org/2001/XMLSchema#string

Humphrey Gardner

http://www.w3.org/2001/XMLSchema#string

Jing-Wei Xiong

http://www.w3.org/2001/XMLSchema#string

Michael J Fitch

http://www.w3.org/2001/XMLSchema#string

William B Kiosses

http://www.w3.org/2001/XMLSchema#string

Zhongmin Zou

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor

Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor

Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4

Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development

The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis

Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis

P304

140-156

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YDBIO.2005.04.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P50

Heidi Stuhlmann

Luisa Campagnolo

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7857990

http://www.w3.org/2001/XMLSchema#string

P698

15882861

http://www.w3.org/2001/XMLSchema#string

P932

1453095

http://www.w3.org/2001/XMLSchema#string